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Fibroblast growth factors (FGFs) play crucial roles in
brain development and neuroprotection and have been
implicated in the susceptibility to schizophrenia
(Terwisscha van Scheltinga et al., 2010). FGF mutant
mice studies suggest that disturbances of FGFs affect
brain structure in vivo. Brain structure is associated
robustly with schizophrenia and is highly heritable. We
systematically screened single nucleotide polymorphisms
(SNPs) in the FGF system for association with intracra-
nial volume, a developmental phenotype affected by
FGFs, and with brain volume, a schizophrenia
endophenotype.
Intracranial volume (corrected for age and sex) and total
brain volume (corrected for age, sex, and intracranial
volume) were measured on a 1.5 T MRI scanner in 162
schizophrenic patients and 151 healthy controls, as
described before (Terwisscha van Scheltinga et al., 2013).
We selected SNPs located in 83 genes, including 22
FGFs, five FGF receptors, and 56 interacting proteins.
After quality control, a set of 915 SNPs genotyped with
the Illumina HumanHap550 beadchip (Illumina, San
Diego, California, USA) was analyzed for effects on these
volumes using analysis of variances. Over-representation
of multiple high-ranking SNPs in CACNA1D (calcium
channel, L-type, α1D subunit, also called Cav1.3) was
tested using a Fisher exact test and with permutation
analysis (randomly permuting intracranial volume 10 000
times while leaving genotype data unchanged).
After Bonferroni correction, no single SNP was associated
significantly with intracranial volume or brain volume.
For intracranial volume, there was a significant over-
representation of SNPs in CACNA1D among the
highest-ranking SNPs (expected number of CACNA1D
SNPs with P< 0.1= 7, observed= 20; over-
representation P-value Fisher exact= 1.0× 10− 5, per-
mutation P-value= 0.004). When taking into account
disease status, CACNA1D SNPs were not significantly
over-represented because some SNPs had effects pre-
dominantly in patients and others in controls. However,
there were no main effects of the CACNA1D SNPs on
disease status, or a gene-based over-representation.
Although there was some linkage disequilibrium
between the high-ranking SNPs, together they explained
more variance in intracranial volume (10.7%) than each
separately (2.4–3.7%).
These results suggest that multiple SNPs in CACNA1D,
each with small effects, influence intracranial volume in
patients as well as controls. Activation of FGF receptors
opens these calcium channels, thereby affecting axon
outgrowth (Archer et al., 1999). Interestingly, the largest
reported genome-wide association study for schizo-
phrenia found multiple hits in calcium channels (Ripke
et al., 2013). We attempted to replicate our findings in an
independent sample of 892 healthy controls, with 1.5 or
3 T MRI scans, genotyped on the Affymetrix GeneChip
6.0 (Affymetrix, Santa Clara, California, USA) [see
Bralten et al. (2011) for a sample description]. Of the 57
SNPs in CACNA1D, only 18 were overlapping with the
Illumina SNPs used in the initial sample. No over-
representation was observed in this second sample
(expected number of CACNA1D SNPs with P< 0.1= 7,
observed= 6). This could mean that our initial finding
was based on stochastic variation. However, different
study characteristics (healthy controls only, different
MRI scanners, and SNP sets) might also explain the
nonreplication. Taken together, SNPs in the FGF sys-
tem do not seem to exert major effects on brain volume
in schizophrenic patients and healthy controls.
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